Insights

Innovative Technology Adoption AxoSim's proprietary microBrain™ organoid platform offers a highly physiologically relevant model for CNS drug discovery and toxicity testing, presenting a valuable tool for pharmaceutical companies seeking advanced neuropsychiatric research solutions.

Recent Leadership Expansion The appointment of new executive and board leadership, including a Vice President of Sales and Marketing, indicates a strategic focus on expanding sales channels and market penetration within the neurobiology and biotech sectors.

Growing Market Presence With recent acquisitions and asset investments from Vyant Bio’s StemoniX, AxoSim is strengthening its portfolio in neurotechnology, opening doors for collaborations and partnership opportunities with companies targeting CNS disorders.

Market Trend Alignment The company's focus on human brain models aligns with industry trends toward more accurate, human-relevant testing platforms, positioning AxoSim as a potential partner for organizations seeking cutting-edge neurodiscovery solutions.

Funding and Revenue Potential Operating in the $1M to $10M revenue range with active growth strategies suggests ample sales opportunities with biotech and pharmaceutical clients aiming to enhance drug development pipelines using advanced organoid models.

Similar companies to StemoniX, acquired by AxoSim

StemoniX, acquired by AxoSim Tech Stack

StemoniX, acquired by AxoSim uses 8 technology products and services including oEmbed, TweenMax, JSON-LD, and more. Explore StemoniX, acquired by AxoSim's tech stack below.

  • oEmbed
    Dev Tools
  • TweenMax
    Javascript Frameworks
  • JSON-LD
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Goober
    Javascript Libraries
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • ZURB Foundation
    UI Frameworks

Media & News

StemoniX, acquired by AxoSim's Email Address Formats

StemoniX, acquired by AxoSim uses at least 2 format(s):
StemoniX, acquired by AxoSim Email FormatsExamplePercentage
First.Last@stemonix.comJohn.Doe@stemonix.com
90%
FirLast@stemonix.comJohDoe@stemonix.com
7%
First_L@stemonix.comJohn_D@stemonix.com
3%
First.Last@axosim.comJohn.Doe@axosim.com
91%
First.M.Last@axosim.comJohn.M.Doe@axosim.com
7%
Fir.Last@axosim.comJoh.Doe@axosim.com
2%

Frequently Asked Questions

Where is StemoniX, acquired by AxoSim's headquarters located?

Minus sign iconPlus sign icon
StemoniX, acquired by AxoSim's main headquarters is located at 13300 67th Avenue North Maple Grove, Minnesota 55311 United States. The company has employees across 1 continents, including North America.

What is StemoniX, acquired by AxoSim's phone number?

Minus sign iconPlus sign icon
You can contact StemoniX, acquired by AxoSim's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is StemoniX, acquired by AxoSim's official website and social media links?

Minus sign iconPlus sign icon
StemoniX, acquired by AxoSim's official website is axosim.com and has social profiles on LinkedInCrunchbase.

What is StemoniX, acquired by AxoSim's SIC code NAICS code?

Minus sign iconPlus sign icon
StemoniX, acquired by AxoSim's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does StemoniX, acquired by AxoSim have currently?

Minus sign iconPlus sign icon
As of March 2026, StemoniX, acquired by AxoSim has approximately 1 employees across 1 continents, including North America. Key team members include Information Technology Manager: D. M.Project Manager: M. W.Administrative Assistant: B. U.. Explore StemoniX, acquired by AxoSim's employee directory with LeadIQ.

What industry does StemoniX, acquired by AxoSim belong to?

Minus sign iconPlus sign icon
StemoniX, acquired by AxoSim operates in the Biotechnology Research industry.

What technology does StemoniX, acquired by AxoSim use?

Minus sign iconPlus sign icon
StemoniX, acquired by AxoSim's tech stack includes oEmbedTweenMaxJSON-LDjQuery MigrateGooberPHPYoast SEOZURB Foundation.

What is StemoniX, acquired by AxoSim's email format?

Minus sign iconPlus sign icon
StemoniX, acquired by AxoSim's email format typically follows the pattern of First.Last@stemonix.com. Find more StemoniX, acquired by AxoSim email formats with LeadIQ.

When was StemoniX, acquired by AxoSim founded?

Minus sign iconPlus sign icon
StemoniX, acquired by AxoSim was founded in 2014.

StemoniX, acquired by AxoSim

Biotechnology ResearchMinnesota, United States0-1 Employees

AxoSim, Inc. acquired the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary in October 2023.

The microBrain™ technology provides a physiologically relevant human iPSC-derived screening platform for CNS drug discovery and toxicity testing. The organoid platform replicates important human CNS biology, containing cortical neurons and astrocytes that self-organize and form functional networks in 3D. The hallmark of the microBrain™ organoids is their remarkably consistent performance, making them ideal for high-throughput neurotoxicology, neuromodulation, and drug discovery investigations.

For more information about microBrain™ contact sales@axosim.com

Section iconCompany Overview

Headquarters
13300 67th Avenue North Maple Grove, Minnesota 55311 United States
Phone number
Website
axosim.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
0-1

Section iconFunding & Financials

  • $1M$10M

    StemoniX, acquired by AxoSim's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    StemoniX, acquired by AxoSim's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.